159 related articles for article (PubMed ID: 7979288)
1. L-651,392, a potent leukotriene inhibitor, controls inflammatory process in Escherichia coli pyelonephritis.
Tardif M; Beauchamp D; Bergeron Y; Lessard C; Gourde P; Bergeron MG
Antimicrob Agents Chemother; 1994 Jul; 38(7):1555-60. PubMed ID: 7979288
[TBL] [Abstract][Full Text] [Related]
2. Experimental pyelonephritis. Route of infection, course and immunological aspects.
Tuan H; Hagemann I; Briedigkeit H; Dutz W
Int Urol Nephrol; 1972; 4(3):285-95. PubMed ID: 4592133
[No Abstract] [Full Text] [Related]
3. Oxidative renal damage in pyelonephritic rats is ameliorated by montelukast, a selective leukotriene CysLT1 receptor antagonist.
Tuğtepe H; Sener G; Cetinel S; Velioğlu-Oğünç A; Yeğen BC
Eur J Pharmacol; 2007 Feb; 557(1):69-75. PubMed ID: 17173892
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of gentamicin in the treatment of renal infection: a therapeutic anomaly explained.
Miller T; Phillips S; North D
Kidney Int; 1979 Feb; 15(2):160-6. PubMed ID: 390210
[No Abstract] [Full Text] [Related]
5. Ozone therapy prevents renal inflammation and fibrosis in a rat model of acute pyelonephritis.
Caliskan B; Guven A; Ozler M; Cayci T; Ozcan A; Bedir O; Surer I; Korkmaz A
Scand J Clin Lab Invest; 2011 Oct; 71(6):473-80. PubMed ID: 21923232
[TBL] [Abstract][Full Text] [Related]
6. Electron microscopic study of acute retrograde pyelonephritis in mice.
Deguchi T; Kuriyama M; Maeda S; Sakai S; Ban Y; Kawada Y; Nishiura T
Urology; 1990 May; 35(5):423-7. PubMed ID: 2186552
[TBL] [Abstract][Full Text] [Related]
7. Transient urethral obstruction predisposes to ascending pyelonephritis and tubulo-interstitial disease: studies in rats.
Bitz H; Darmon D; Goldfarb M; Shina A; Block C; Rosen S; Brezis M; Heyman SN
Urol Res; 2001 Feb; 29(1):67-73. PubMed ID: 11310219
[TBL] [Abstract][Full Text] [Related]
8. Host response to porcine strains of Escherichia coli in a novel pyelonephritis model.
Isling LK; Aalbæk B; Birck MM; Heegaard PM; Leifsson PS
J Comp Pathol; 2011 May; 144(4):257-68. PubMed ID: 21159351
[TBL] [Abstract][Full Text] [Related]
9. Chronic pyelonephritis. Electron microscopic study. II. Persistence of variant bacterial forms.
Smith TW; Roberts JA
Invest Urol; 1978 Sep; 16(2):154-62. PubMed ID: 361629
[TBL] [Abstract][Full Text] [Related]
10. The therapeutic response of cephalosporin-treated E. coli pyelonephritis of the rat, in relation to variations of the infection model.
Schulz E; Marre R; Herhahn D; Sack K
Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Jul; 259(4):531-7. PubMed ID: 3901618
[TBL] [Abstract][Full Text] [Related]
11. Role of antioxidant defence, renal toxicity markers and inflammatory cascade in disease progression of acute pyelonephritis in experimental rat model.
Vysakh A; Raji NR; Suma D; Jayesh K; Jyothis M; Latha MS
Microb Pathog; 2017 Aug; 109():189-194. PubMed ID: 28578087
[TBL] [Abstract][Full Text] [Related]
12. Androgen exposure potentiates formation of intratubular communities and renal abscesses by Escherichia coli.
Olson PD; McLellan LK; Hreha TN; Liu A; Briden KE; Hruska KA; Hunstad DA
Kidney Int; 2018 Sep; 94(3):502-513. PubMed ID: 30041870
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and toxicity of gentamicin in an experimental model of pyelonephritis: effect of the time of administration.
LeBrun M; Grenier L; Gourde P; Bergeron MG; Labrecque G; Beauchamp D
Antimicrob Agents Chemother; 1999 May; 43(5):1020-6. PubMed ID: 10223909
[TBL] [Abstract][Full Text] [Related]
14. The ultrastructure of acute pyelonephritis in the monkey.
Fussell EN; Roberts JA
J Urol; 1984 Jul; 132(1):179-83. PubMed ID: 6427482
[TBL] [Abstract][Full Text] [Related]
15. Chronic pyelonephritis. An electron microscopic study in nonhuman primates.
Smith TW; Roberts JA
Invest Urol; 1978 Sep; 16(2):148-53. PubMed ID: 101481
[TBL] [Abstract][Full Text] [Related]
16. Tissue distribution of neutrophils in postischemic acute renal failure.
Willinger CC; Schramek H; Pfaller K; Pfaller W
Virchows Arch B Cell Pathol Incl Mol Pathol; 1992; 62(4):237-43. PubMed ID: 1359696
[TBL] [Abstract][Full Text] [Related]
17. Pyelonephritis in slaughter pigs and sows: morphological characterization and aspects of pathogenesis and aetiology.
Isling LK; Aalbaek B; Schrøder M; Leifsson PS
Acta Vet Scand; 2010 Aug; 52(1):48. PubMed ID: 20704704
[TBL] [Abstract][Full Text] [Related]
18. Acute human pyelonephritis: leukocytic infiltration of tubules and localization of bacteria.
Iványi B; Rumpelt HJ; Thoenes W
Virchows Arch A Pathol Anat Histopathol; 1988; 414(1):29-37. PubMed ID: 3144801
[TBL] [Abstract][Full Text] [Related]
19. Temocillin breakpoints in pyelonephritis: evaluation in a murine model due to ESBL-producing Escherichia coli clinical isolates.
Alexandre K; Soares A; Chau F; Fantin B; Caron F; Etienne M
J Antimicrob Chemother; 2019 May; 74(5):1323-1326. PubMed ID: 30689887
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effects of 5,2'-dibromo-2,4',5'-trihydroxydiphenylmethanone (LM49) in an experimental rat model of acute pyelonephritis by immunomodulation and anti-inflammation.
Zhang YL; Feng XE; Chang RR; Zhang LH; Xiao BG; Li QS; Hao XL
Int Immunopharmacol; 2018 Sep; 62():155-164. PubMed ID: 30007245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
